Navigation Links
miVac Duo Concentrator from GeneVac, Inc.

ProductsmiVac Duo Concentrator from GeneVac, Inc.
Company GeneVac, Inc.
Item miVac Duo Concentrator
Price 
Description The miVac Duo is suitable for use with a wide range of solvents, from volatile organic solvents through to water and some of the higher boiling point solvents.

A centrifugal concentrator capable of removing water and organic solvents from a variety of sample formats including tubes, microplates, vials and round bottom flasks; making it an ideal "work-horse" concentrator for the busy lab.

The built-in special runs for working with water and water mixtures improve performance and optimise concentration time and make the miVac Duo ideal for applications requiring concentration of solvent from precious samples in: Oligo-synthesis, RNA/DNA prep., peptide prep., sequencing, molecular biology, ADME / toxicology labs, process development, residue analysis, environmental analysis and general academic/life science research.

Combine the miVac Duo with our optional miVac SpeedTrap and/or pump(s) to increase performance even further.

Capacity:
Key Features:

  • Advanced technology controls heating providing protection for valuable samples.
  • Solid state electro-magnetic drive for quiet, maintenance free operation.
  • Very easy to use simple, clear user interface.
  • Low cost of ownership.
  • Well built and quiet operation.
  • Manufactured in the UK under ISO 9001 standard.
Info GeneVac, Inc.GeneVac, Inc.
707 Executive Boulevard, Suite D
Valley Cottage, NY 10989
Customer Service: 845-267-2211
Fax Number: 845-267-2212
Web Site: http://www.genevac.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. miVacDNA Concentrator from GeneVac, Inc.
2. SPD131DDA SpeedVac Concentrator from Thermo Scientific
3. SC210A SpeedVac Concentrator from Thermo Scientific
4. SPD101B Basic SpeedVac Concentrator from Thermo Scientific
5. SC110A SpeedVac Concentrator from Thermo Scientific
6. SC250 Express SpeedVac Concentrator from Thermo Scientific
7. SPD121P SpeedVac Concentrator from Thermo Scientific
Rabbit Anti-Human DAP-1 Monoclonal Antibody, Unconjugated from Upstate
Mouse Anti-Angiotensin II Type 1 Receptor Monoclonal Antibody, Unconjugated, Clone TONI-1 from Abcam
1/4" to 1/8" Adapter for Reflectance Probe Holder from Ocean Optics
...amide (GLP-1), C-terminal reactive. Cross-reacts f...reactivity with the unamidated forms GLP-1(7-37) a...GLP-2, glucagon, hGIP and VIP.,SPECIES REACTIVIT... all mammalian species studied except guinea pig a...
Biology Products:
(Date:11/26/2009)...s Aureus ) and other drug-resistant bacteria could...type devices have been developed to offer safe, qu... Two prototype devices have been developed: one f...nds and feet) in hospitals and public spaces where... shoot bacteria-killing agents into infested chron...
(Date:11/25/2009)...cers and ambulance workers faced a terrifying resc...battled to save people from the collapsing Twin To...acuated as many people as they could in an area wh...ng their jobs even harder was the problem of poor ...ives jammed mobile networks with calls and the eme...
(Date:11/25/2009)...sors recently received funding from the National S...icial to understanding the environment. The three ...assistant professor in the Department of Biologica...rate research projects. , His first project, tit...Functions from the Leaf to the Landscape," will ex...
Breaking Biology News(10 mins):Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Magic box for mission impossible 2Magic box for mission impossible 3Kent State University professors focus research on the environment with grants totaling $890,000 2JAG Media Holdings Inc Announces Completion of Acquisition of CardioGenics Inc 53384 1JAG Media Holdings Inc Announces Completion of Acquisition of CardioGenics Inc 53384 2JAG Media Holdings Inc Announces Completion of Acquisition of CardioGenics Inc 53384 3JAG Media Holdings Inc Announces Completion of Acquisition of CardioGenics Inc 53384 4Duane Reade Holdings Inc Announces Pricing of Offering of 11 75 25 Senior Secured Notes Due 2015 53380 1Duane Reade Holdings Inc Announces Pricing of Offering of 11 75 25 Senior Secured Notes Due 2015 53380 2Duane Reade Holdings Inc Announces Pricing of Offering of 11 75 25 Senior Secured Notes Due 2015 53380 3INVEGA 28R 29 Approved as the First and Only Treatment for Schizoaffective Disorder 53377 1INVEGA 28R 29 Approved as the First and Only Treatment for Schizoaffective Disorder 53377 2INVEGA 28R 29 Approved as the First and Only Treatment for Schizoaffective Disorder 53377 3INVEGA 28R 29 Approved as the First and Only Treatment for Schizoaffective Disorder 53377 4INVEGA 28R 29 Approved as the First and Only Treatment for Schizoaffective Disorder 53377 5INVEGA 28R 29 Approved as the First and Only Treatment for Schizoaffective Disorder 53377 6INVEGA 28R 29 Approved as the First and Only Treatment for Schizoaffective Disorder 53377 7
..., Calif.) A new study by researchers at UC Davis ...d deaths of some epilepsy patients may be a result...he during seizures. , "Significant drops in blood...patients with partial seizures," said study senior...C Davis Medical Center and director of the UC Davi...
...- (Nov. 17, 2008) -- A "chip" or array that can qu...her diseases associated with chromosomal abnormali...s in a series of 300 cases at Baylor College of Me...in the current issue of the journal Prenatal Diag... Beaudet and Dr. Sau Wai Cheung at BCM, described ...
...family history of prostate cancer and African-Amer...se, with a twofold to sevenfold increased risk. As...lt. , "There have been years of effort to try to ...th prostate cancer as there are for breast cancer,...e Cancer Risk Assessment Program (PRAP) at Fox Cha...
Other Biology News:Drops in blood oxygen levels may be key to sudden death in some epilepsy patients 2Drops in blood oxygen levels may be key to sudden death in some epilepsy patients 3Microarray analysis improves prenatal diagnosis 2Microarray analysis improves prenatal diagnosis 3Genetic risk factors may tailor prostate cancer screening approaches 2
(Date:11/27/2009)... , DURHAM, N.C., Nov. 27 ...ll initiate water-soluble carbon nanotube-based ca... water-soluble carbon nanotubes, which have functi...on with cancer drugs, was developed in partnership...njugated carbon nanotubes serves as a drug deliver...
(Date:11/25/2009)... , BOSTON, Nov. 25 Biotec... virus, genomic data from the 1918 pandemic throug...rrent H1N1 pandemic, today issued its latest bioch...hat the lethality of the H1N1 ("Swine Flu") virus ... the virus,s current outbreak in the spring of 200...
(Date:11/25/2009)... , NEW YORK, Nov. 25 Repo...report is available in its catalogue: ,, Brazi... ,, http://www.reportlinker.com/p0165503/Braz...3.html ,, Brazil Bioethanol Market Analysis an...rt provides detailed analysis and forecasts of the...
(Date:11/24/2009)... The New York investment bank K...X:NEU) has agreed an AU$6.7 mil convertible note p...r. The private placement was arranged by KTA Capit...or. , New York (PRWEB) No...ment bank KTA Capital, LLC ("KTA Capital"...
Breaking Biology Technology:North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2